The Neuron: AI Explained

BONUS: The AI Starter Kit: What to Try...and What to Ignore

The Neuron: AI Explained

Show Notes

New to AI and not sure where to start?

Join us live Thursday for The AI Starter Kit: What to Try...and What to Ignore.

This beginner-friendly session will help you cut through the noise and focus on the AI tools, habits, and prompts that actually matter. By the end, you’ll know what to try first, what not to worry about yet, and how to ask better questions when you get stuck.

In this session, we’ll cover: 🚀 The best first steps for AI beginners 🛠️ What tools and features are worth trying now 🙅 What you can safely ignore for the moment 💡 Simple ways to get better answers from AI 🔍 How to troubleshoot when AI gives you something unhelpful

Whether you’re brand new to AI or still figuring out how to use it well, this live session will give you a practical place to start.

More from The Neuron: AI Explained

Oct 21, 2026

Neurosurgeon-scientists Alex Ksendzovsky and Jon Pomeraniec explain how The Biological Computing Company uses living neurons as a research platform for AI. Their team grows roughly 150,000 cells on a 4,096-electrode array, sends in patterns such as handwritten digits, records how the neurons respond, and models useful computational behaviors in software. They say those neuron-inspired techniques are already helping GPU-based video-generation systems run about 5x faster with roughly 80% lower inference cost, while their longer-term work explores robots, world models, and real-time biological compute.

Oct 16, 2026

OpenAI just dropped 20+ announcements at DevDay 2026, so... yeah, we have some things to talk about. 😺

Oct 14, 2026

Runway co-founder Anastasis Germanidis explains Solaris, an “interface world model” that generates software frame by frame instead of rendering a traditional interface from HTML and CSS.

Oct 9, 2026

OpenAI DevDay 2026 is here, and we’re hosting a watch party to watch the keynote LIVE.

Oct 8, 2026

Corey and Grant sit down with Mammoth Biosciences co-founder and CEO Dr. Trevor Martin to explain how CRISPR is moving from a laboratory tool toward one-time medicines.

See all episodes →